Groundbreaking studies in Concord, California

Cadex Genomics, located at 541 Jefferson Avenue in Redwood City, California, is dedicated to improving the lives of cancer patients through the development of innovative blood-based assays. Their upcoming product, Alibrex®, is a groundbreaking blood test designed to identify stage IV cancer patients experiencing disease progression in real-time. Unlike the current standard of care which takes three months to assess treatment effectiveness, Alibrex allows oncologists to determine if a patient's treatment is working in just 12 days after starting therapy. By measuring the concentration of DNA in the blood before and after treatment, Alibrex can detect even the smallest changes indicative of tumor growth or treatment ineffectiveness.

The John Muir Health Clinical Research Center, located at 2700 Grant Street in Concord, California, is a leading institution dedicated to advancing medical knowledge and improving patient care through innovative research. Our team of experienced healthcare professionals and researchers work tirelessly to conduct groundbreaking clinical trials and studies in various medical specialties. Patients have the opportunity to participate in cutting-edge research that can potentially lead to new treatments and therapies. With a commitment to excellence and a focus on patient-centered care, the John Muir Health Clinical Research Center is at the forefront of medical research in the United States.